BHC Valeant Pharmaceuticals: Utang jangka cendhak perusahaan

Bausch Health Companies (BHC) competes in the dermatology and gastroenterology segments, seeking to reduce debt through asset sales. This chart on GURU.Markets reflects liquidity dynamics for the short-term debt portfolio, with the indicator holding around 0.00. Management aims to unlock business value by optimizing the corporate structure. The holding's resilience is based on a wide range of ophthalmological and cosmetic products.

bauschhealth.com (BHC) - Silihan lan utang jangka cendhak perusahaan saka 04.07.2022 nganti 30.10.2026

Rincian analitis lan laporan data perusahaan Bausch Health Corp (BHC)

- kuotasi saiki lan rata-rata prakiraan nilai:

Bagan rega Bausch Health|BHC - Target konsensus

- data kapitalisasi saham perusahaan:

Kapitalisasi pasar Bausch Health Companies Inc.|BHC - Nilai Perusahaan

- rincian valuasi buku bisnis:

Nilai Akuntansi saben Saham Bausch Health|BHC - Nilai Akuntansi Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku bauschhealth.com|BHC - Nilai Agregat Aset

- data tingkat utang lan likuiditas finansial:

Utang marang Ekuitas Bausch Health Companies|BHC - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Bausch Health Companies|BHC - Utang perusahaan|Utang-utang marang kapitalisasi buku Bausch Health Companies Inc.|BHC - Tanggungan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Bausch Health|Likuiditas cepet bauschhealth.com

- indikator bathi lan kelipatan valuasi:

BHC - Bathi perusahaan

Pambiji fundamental perusahaan:Bausch Health (BHC)

Steady demand for Bausch Health Companies (BHC) ophthalmology solutions ensures a consistent cash flow to service obligations. By analyzing short-term borrowings due within one year, an investor assesses the aggregate of loans and bonds maturing within twelve months, which allows for the determination of liquidity risk and the impact of current payments on free cash flow and the holding's overall financial stability.

Pesaing langsung